Prescription drug · NDA
Bryhali (Halobetasol propionate) NDC 0187-0002
Halobetasol propionate .1 mg/g · Lotion · Topical · Bausch Health US, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0187-0002-01 | 00187000201 | 1 TUBE in 1 CARTON (0187-0002-01) / 100 g in 1 TUBEMarketed from Nov 6, 2018 | |
| 0187-0002-03 | 00187000203 | 1 TUBE in 1 CARTON (0187-0002-03) / 3 g in 1 TUBEMarketed from Nov 6, 2018 · Sample package | |
| 0187-0002-60 | 00187000260 | 1 TUBE in 1 CARTON (0187-0002-60) / 60 g in 1 TUBEMarketed from Nov 6, 2018 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bryhali
- Generic name (nonproprietary)
- halobetasol propionate
- Active ingredients
- Halobetasol propionate — .1 mg/g
- Dosage form
- Lotion
- Route
- Topical
- Labeler
- Bausch Health US, LLCNDC labeler code 0187
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 209355
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 0187-0002_e14757d5-86ff-41a8-8bde-14065af6899eSPL ID e14757d5-86ff-41a8-8bde-14065af6899eSPL set ID d4bbb66a-3f9d-4091-b1b0-1cbc908432d3RxCUI 2101710, 2101715UNII 91A0K1TY3Z
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400187000201followed by a unit qualifier and the quantityPackage 00187-0002-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
BRYHALI ® (halobetasol propionate) lotion, 0.01% is indicated for the topical treatment of plaque psoriasis in adults. BRYHALI lotion is a corticosteroid indicated for the topical treatment of plaque psoriasis in adults. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0187-0002
- What is NDC 0187-0002?
- 0187-0002 is the product NDC for Bryhali (halobetasol propionate), Halobetasol propionate .1 mg/g lotion, listed with the FDA by Bausch Health US, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Bryhali (Halobetasol propionate).
- What is the active ingredient?
- Halobetasol propionate.
- Who is the labeler?
- Bausch Health US, LLC, NDC labeler code 0187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Bryhali?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.